Firstrand Ltd (FSR)
Johannesburg Stock Exchange · South Africa · prices in ZAC · close of 27 Oct 2026
Key indicators
| Last close | ZAC 9,204.00 |
|---|---|
| 52-week range | 7,833.00 – 10,288.00 |
| Return, 1 month / 3 months | +3.3% / −1.3% |
| Return, 1 year / 3 years | +19.9% / +84.3% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 23.1% |
| Worst drawdown (1 year) | -13.3% |
| Average daily value traded | 108,498.60M ZAC |
| Dividend yield | 5.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
FirstRand is a South African financial services group based in Johannesburg. Through its divisions it offers retail and commercial banking, investment banking, vehicle and asset finance, and asset management. Its customers include individual savers and borrowers, small and medium businesses, large corporations and institutional investors, mainly in South Africa and other African markets. The group provides everyday banking accounts, lending, insurance and wealth products alongside corporate finance and advisory services.
Firstrand Ltd trades under the code FSR on the Johannesburg Stock Exchange in South Africa, with its price quoted in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Firstrand Ltd (FSR) trades on the Johannesburg Stock Exchange in South Africa. It last closed at ZAC 9,204.00 on 27 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 24 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.9% and over the last three months it fell 1.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.8% | ||
| From 52-week high | -9.3% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.3% | ||
| 6-month return | 7.9% | ||
| 12-month return, skipping the last month | 16.1% | ||
| Stability (higher is calmer) | 87 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.3% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 108,498.60M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.9% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.0% |
|---|---|
| 1 month | +3.3% |
| 3 months | −1.3% |
| 6 months | +7.9% |
| 1 year | +19.9% |
| 3 years | +84.3% |
| 5 years | +111.1% |
Signals
| 50-day / 200-day average | 9,098.34 / 8,956.75 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 177.37 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Oct 2026 | ZAC 280.0000 |
| 31 Mar 2026 | ZAC 259.0000 |
| 8 Oct 2025 | ZAC 247.0000 |
| 2 Apr 2025 | ZAC 219.0000 |
| 9 Oct 2024 | ZAC 215.0000 |
| 26 Mar 2024 | ZAC 200.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.